Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
在新冠肺炎住院幸存者出院早期预防性使用利伐沙班可降低房颤住院率和长期随访期间猝死发生率。
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1093396
Fiedler, Lukas; Motloch, Lukas J; Dieplinger, Anna-Maria; Jirak, Peter; Davtyan, Paruir; Gareeva, Diana; Badykova, Elena; Badykov, Marat; Lakman, Irina; Agapitov, Aleksandr; Sadikova, Liana; Pavlov, Valentin; Föttinger, Fabian; Mirna, Moritz; Kopp, Kristen; Hoppe, Uta C; Pistulli, Rudin; Cai, Benzhi; Yang, Baofeng; Zagidullin, Naufal
